NQPC-05 BEVACIZUMAB AFTER PROGRESSION OF GLIOBLASTOMA PROLONGS PATIENT’S LIVING TIME AT HOME IN THE LAST 90 DAYS

por Matsutani, Tomoo, Hirono, Seiichiro, Iwadate, Yasuo
Publicado 2019

STMO-05 SURGICAL AND FUNCTIONAL OUTCOME OF AWAKE SURGERY FOR INSULAR GLIOMA

por Hirono, Seiichiro, Matsutani, Tomoo, Iwadate, Yasuo
Publicado 2019

STMO-11 Supratotal resection of Glioblastoma with Methionine PET

por Ko, Ozaki, Hirono, Seiichiro, Matsutani, Tomoo, Iwadate, Yasuo
Publicado 2020

Molecular imaging of 1p/19q deletion in oligodendroglial tumours with (11)C-methionine positron emission tomography

por Iwadate, Yasuo, Shinozaki, Natsuki, Matsutani, Tomoo, Uchino, Yoshio, Saeki, Naokatsu
Publicado 2016

STMO-13 PATHOLOGICAL EVALUATION AND ONCOLOGICAL OUTCOME OF FLAIRECTOMY IN PATIENTS WITH IDH1 WILD-TYPE GLIOBLASTOMA

por Hirono, Seiichiro, Kouchi, Yusuke, Kishimoto, Takashi, Kobayashi, Masayoshi, Matsutani, Tomoo, Iwadate, Yasuo
Publicado 2022

Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomas

por Matsutani, Tomoo, Hiwasa, Takaki, Takiguchi, Masaki, Oide, Takashi, Kunimatsu, Mitoshi, Saeki, Naokatsu, Iwadate, Yasuo
Publicado 2012

Real-time methylation-specific PCR for the evaluation of methylation status of MGMT gene in glioblastoma

por Yoshioka, Masaki, Matsutani, Tomoo, Hara, Ayaka, Hirono, Seiichiro, Hiwasa, Takaki, Takiguchi, Masaki, Iwadate, Yasuo
Publicado 2018

GCT-09. HEALTH AND SOCIAL ISSUES IN THE LONG-TERM GERM-CELL TUMOR SURVIVORS

por Matsutani, Tomoo, Horiguchi, Kentaro, Ikegami, Shiro, Hirono, Seiichiro, Murai, Hisayuki, Saeki, Naokatsu, Iwadate, Yasuo
Publicado 2020

Oncological and functional outcomes of supratotal resection of IDH1 wild-type glioblastoma based on (11)C-methionine PET: a retrospective, single-center study

por Hirono, Seiichiro, Ozaki, Ko, Kobayashi, Masayoshi, Hara, Ayaka, Yamaki, Tomohiro, Matsutani, Tomoo, Iwadate, Yasuo
Publicado 2021

STMO-3 Mid- to long-term outcome of supratotal resection of IDH1 wild-type glioblastoma based on 11C-methionine PET: a retrospective, single-center study

por Hirono, Seiichiro, Ozaki, Ko, Kobayashi, Masayoshi, Hara, Ayaka, Yamaki, Tomohiro, Matsutani, Tomoo, Iwadate, Yasuo
Publicado 2021

GCT-45. YOLK SAC TUMOR IN THE CEREBELLAR VERMIS - A CASE REPORT

por Otake, Saori, Matsutani, Tomoo, Watanabe, Yousuke, Numata, Osamu, Ando, Ryo, Ochiai, Hidemasa, Junichiro, Ikeda, Iwadate, Yasuo
Publicado 2020

PATH-03. HIGH-GRADE NEUROEPITHELIAL TUMOR SHOWING BCOR IMMUNOPOSITIVITY WITHOUT EXON 15 INTERNAL TANDEM DUPLICATIONS IN A FIVE-YEAR-OLD BOY: A CASE REPORT

por Wakita, Shogo, Matsutani, Tomoo, Watanabe, Yosuke, Hirono, Seiichiro, Higuchi, Yoshinori, Iwadate, Yasuo, Ikeda, Zyunichiro, Yokoo, Hideaki
Publicado 2020

Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas

por Adachi-Hayama, Masayo, Adachi, Akihiko, Shinozaki, Natsuki, Matsutani, Tomoo, Hiwasa, Takaki, Takiguchi, Masaki, Saeki, Naokatsu, Iwadate, Yasuo
Publicado 2014

CS-1 Cerebellar liponeurocytoma; Report of two cases with detailed metabolic, immunohistochemical, and genetic evaluations

por Shimizu, Miyuki, Origuchi, Shinichi, Hirono, Seiichiro, Matsutani, Tomoo, Oota, Masayuki, Ikeda, Jun-Ichiro, Yokoo, Hideaki, Iwadate, Yasuo
Publicado 2021

ACT-18 SHOULD THE DOSE OF TEMOZOLOMIDE BE DECREASED FOR PATIENTS WITH HIGH-GRADE GLIOMAS WHO ARE ON HEMODIALYSIS?

por Muto, Jun, Matsutani, Tomoo, Matsuda, Ryosuke, Kinoshita, Masashi, Oikawa, Mitsuteru, Johan, Pallud, Adachi, Kazuhide, Hirose, Yuichi, Sasaki, Hikaru
Publicado 2019

Clinicopathological and Genomic Features of Pediatric Intracranial Myxoid Mesenchymal Tumor with both of EWSR1-CREM Gene Fusion and MAP3K13 Mutation: A Case Report and Comparison w...

por SASAKI, Minami, HIRONO, Seiichiro, GAO, Yue, SUDA, Izumi, MATSUTANI, Tomoo, OTA, Masayuki, KISHIMOTO, Takashi, IKEDA, Jun-Ichiro, YOKOO, Hideaki, IWADATE, Yasuo
Publicado 2022

Serum anti-SERPINE1 antibody as a potential biomarker of acute cerebral infarction

por Kubota, Masaaki, Yoshida, Yoichi, Kobayashi, Eiichi, Matsutani, Tomoo, Li, Shu-Yang, Zhang, Bo-Shi, Mine, Seiichiro, Machida, Toshio, Takizawa, Hirotaka, Hiwasa, Takaki, Iwadate, Yasuo
Publicado 2021

CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy

por Hara, Ayaka, Koyama-Nasu, Ryo, Takami, Mariko, Toyoda, Takahide, Aoki, Takahiro, Ihara, Fumie, Kobayashi, Masayoshi, Hirono, Seiichiro, Matsutani, Tomoo, Nakayama, Toshinori, Iwadate, Yasuo, Motohashi, Shinichiro
Publicado 2020

MPC-8 Serum anti-zinc finger FYVE domain-containing protein 21 (ZFYVE21) autoantibody as a novel biomarker for oligodendroglioma IDH-mutant and 1p/19q co-deletion

por Matsutani, Tomoo, Boshi, Zhang, Hirono, Seiichiro, Nagane, Motoo, Yoshino, Atsuo, Tanaka, Shouta, Ishikawa, Eiichi, Fukami, Shinziro, Yamaguchi, Fumio, Li, Shuyang, Watanabe, Yousuke, Kobayashi, Masayoshi, Ikegami, Shiro, Hiwasa, Takaki, Iwadate, Yasuo
Publicado 2021

Serum anti‑TSTD2 antibody as a biomarker for atherosclerosis‑induced ischemic stroke and chronic kidney disease

por Kubota, Masaaki, Zhang, Bo-Shi, Li, Shu-Yang, Yoshida, Yoichi, Wang, Hao, Adachi, Akihiko, Matsutani, Tomoo, Mine, Seiichiro, Machida, Toshio, Kamitsukasa, Ikuo, Wada, Takeshi, Aotsuka, Akiyo, Kitamura, Kenichiro, Takizawa, Hirotaka, Kuroda, Hideyuki, Iwadate, Yasuo, Hiwasa, Takaki
Publicado 2022